Hydroxychloroquine doesn’t just block viruses — according to Dr. Richard Urso

(America’s Frontline Doctors), data from a chloroquine study showed it can protect normal cells while allowing viruses to attack cancer cells (the study used Calu-3 lung adenocarcinoma cells).

A cheap, decades-old drug with this selective effect would threaten the multi-trillion-dollar oncology industry overnight.

They don’t want cures. They want lifetime customers for chemo, radiation, and expensive new drugs.